IMR Press / RCM / Volume 12 / Issue S1 / DOI: 10.3909/ricm12S1S0005
Open Access Review
Antiplatelet Therapy, Cardiac Surgery, and the Risk of Bleeding: The Surgeon's Perspective
Show Less
1 Valley Heart and Vascular Institute, Ridgewood, NJ
Rev. Cardiovasc. Med. 2011 , 12(S1), 40–46; https://doi.org/10.3909/ricm12S1S0005
Published: 20 January 2011
Abstract
Antiplatelet therapy is widely accepted in the contemporary management of patients with coronary syndromes. Effective platelet inhibition can cause an increased risk of bleeding, which is more evident when patients are referred to surgical coronary revascularization. The cardiac surgeon should be familiar with all new antiplatelet drugs. In this article we compile the latest information about antiplatelet therapy and its impact on cardiac surgery.
Keywords
Antiplatelet therapy
Cardiac surgery
Bleeding complications
Share
Back to top